253 related articles for article (PubMed ID: 30959822)
1. Transcriptomic Response to 1,25-Dihydroxyvitamin D in Human Fibroblasts with or without a Functional Vitamin D Receptor (VDR): Novel Target Genes and Insights into VDR Basal Transcriptional Activity.
Costa PLF; França MM; Katayama ML; Carneiro ET; Martin RM; Folgueira MAK; Latronico AC; Ferraz-de-Souza B
Cells; 2019 Apr; 8(4):. PubMed ID: 30959822
[TBL] [Abstract][Full Text] [Related]
2. 1alpha,25-Dihydroxyvitamin D(3) antiproliferative actions involve vitamin D receptor-mediated activation of MAPK pathways and AP-1/p21(waf1) upregulation in human osteosarcoma.
Wu W; Zhang X; Zanello LP
Cancer Lett; 2007 Aug; 254(1):75-86. PubMed ID: 17412493
[TBL] [Abstract][Full Text] [Related]
3. Enhanced coactivator binding and transcriptional activation of mutant vitamin D receptors from patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets by phosphorylation and vitamin D analogs.
Liu Y; Shen Q; Malloy PJ; Soliman E; Peng X; Kim S; Pike JW; Feldman D; Christakos S
J Bone Miner Res; 2005 Sep; 20(9):1680-91. PubMed ID: 16059639
[TBL] [Abstract][Full Text] [Related]
4. SIRT1 enzymatically potentiates 1,25-dihydroxyvitamin D
Sabir MS; Khan Z; Hu C; Galligan MA; Dussik CM; Mallick S; Stone AD; Batie SF; Jacobs ET; Whitfield GK; Haussler MR; Heck MC; Jurutka PW
J Steroid Biochem Mol Biol; 2017 Sep; 172():117-129. PubMed ID: 28636886
[TBL] [Abstract][Full Text] [Related]
5. A rationale for treatment of hereditary vitamin D-resistant rickets with analogs of 1 alpha,25-dihydroxyvitamin D(3).
Gardezi SA; Nguyen C; Malloy PJ; Posner GH; Feldman D; Peleg S
J Biol Chem; 2001 Aug; 276(31):29148-56. PubMed ID: 11369766
[TBL] [Abstract][Full Text] [Related]
6. Hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia resulting from a novel missense mutation in the DNA-binding domain of the vitamin D receptor.
Malloy PJ; Wang J; Srivastava T; Feldman D
Mol Genet Metab; 2010 Jan; 99(1):72-9. PubMed ID: 19815438
[TBL] [Abstract][Full Text] [Related]
7. Anti-proliferative action of vitamin D in MCF7 is still active after siRNA-VDR knock-down.
Costa JL; Eijk PP; van de Wiel MA; ten Berge D; Schmitt F; Narvaez CJ; Welsh J; Ylstra B
BMC Genomics; 2009 Oct; 10():499. PubMed ID: 19863778
[TBL] [Abstract][Full Text] [Related]
8. Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness.
Malloy PJ; Eccleshall TR; Gross C; Van Maldergem L; Bouillon R; Feldman D
J Clin Invest; 1997 Jan; 99(2):297-304. PubMed ID: 9005998
[TBL] [Abstract][Full Text] [Related]
9. Stable expression of human VDR in murine VDR-null cells recapitulates vitamin D mediated anti-cancer signaling.
Keith ME; LaPorta E; Welsh J
Mol Carcinog; 2014 Apr; 53(4):286-99. PubMed ID: 23681781
[TBL] [Abstract][Full Text] [Related]
10. Two new unrelated cases of hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia resulting from the same novel nonsense mutation in the vitamin D receptor gene.
Forghani N; Lum C; Krishnan S; Wang J; Wilson DM; Blackett PR; Malloy PJ; Feldman D
J Pediatr Endocrinol Metab; 2010 Aug; 23(8):843-50. PubMed ID: 21073129
[TBL] [Abstract][Full Text] [Related]
11. The Tumor Suppressor FBW7 and the Vitamin D Receptor Are Mutual Cofactors in Protein Turnover and Transcriptional Regulation.
Salehi-Tabar R; Memari B; Wong H; Dimitrov V; Rochel N; White JH
Mol Cancer Res; 2019 Mar; 17(3):709-719. PubMed ID: 30606768
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel vitamin D receptor interacting proteins that modulate 1,25-dihydroxyvitamin D3 signaling.
Marshall PA; Hernandez Z; Kaneko I; Widener T; Tabacaru C; Aguayo I; Jurutka PW
J Steroid Biochem Mol Biol; 2012 Oct; 132(1-2):147-59. PubMed ID: 22626544
[TBL] [Abstract][Full Text] [Related]
13. Diverse Regulation of Vitamin D Receptor Gene Expression by 1,25-Dihydroxyvitamin D and ATRA in Murine and Human Blood Cells at Early Stages of Their Differentiation.
Janik S; Nowak U; Łaszkiewicz A; Satyr A; Majkowski M; Marchwicka A; Śnieżewski Ł; Berkowska K; Gabryś M; Cebrat M; Marcinkowska E
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28635660
[TBL] [Abstract][Full Text] [Related]
14. A novel inborn error in the ligand-binding domain of the vitamin D receptor causes hereditary vitamin D-resistant rickets.
Malloy PJ; Zhu W; Zhao XY; Pehling GB; Feldman D
Mol Genet Metab; 2001 Jun; 73(2):138-48. PubMed ID: 11386849
[TBL] [Abstract][Full Text] [Related]
15. c-Jun NH2-teminal kinase 1 interacts with vitamin D receptor and affects vitamin D-mediated inhibition of cancer cell proliferation.
Bi X; Shi Q; Zhang H; Bao Y; Hu D; Pohl N; Fang W; Dong H; Xia X; Fan D; Yang W
J Steroid Biochem Mol Biol; 2016 Oct; 163():164-72. PubMed ID: 27174721
[TBL] [Abstract][Full Text] [Related]
16. Curcumin: a novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention.
Bartik L; Whitfield GK; Kaczmarska M; Lowmiller CL; Moffet EW; Furmick JK; Hernandez Z; Haussler CA; Haussler MR; Jurutka PW
J Nutr Biochem; 2010 Dec; 21(12):1153-61. PubMed ID: 20153625
[TBL] [Abstract][Full Text] [Related]
17. The prostate cancer TMPRSS2:ERG fusion synergizes with the vitamin D receptor (VDR) to induce CYP24A1 expression-limiting VDR signaling.
Kim JS; Roberts JM; Bingman WE; Shao L; Wang J; Ittmann MM; Weigel NL
Endocrinology; 2014 Sep; 155(9):3262-73. PubMed ID: 24926821
[TBL] [Abstract][Full Text] [Related]
18. VDR in salivary gland homeostasis and cancer.
DeSantis KA; Robilotto SL; Matson M; Kotb NM; Lapierre CM; Minhas Z; Leder AA; Abdul K; Facteau EM; Welsh J
J Steroid Biochem Mol Biol; 2020 May; 199():105600. PubMed ID: 31958633
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D receptor activation reduces VCaP xenograft tumor growth and counteracts ERG activity despite induction of TMPRSS2:ERG.
Roberts JM; Martin RS; Piyarathna DB; MacKrell JG; Rocha GV; Dodge JA; Coarfa C; Krishnan V; Rowley DR; Weigel NL
Oncotarget; 2017 Jul; 8(27):44447-44464. PubMed ID: 28591703
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of vitamin D receptor in mammospheres: implications for vitamin D resistance in breast cancer and potential for combination therapy.
Pervin S; Hewison M; Braga M; Tran L; Chun R; Karam A; Chaudhuri G; Norris K; Singh R
PLoS One; 2013; 8(1):e53287. PubMed ID: 23341935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
